VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRESW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CRESWCresud S.A. Warrant 2021-08.03.26 on Cresud
$0.03$20M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCRESWFinancials

Cresud S.A. Warrant 2021-08.03.26 on Cresud (CRESW) Financials

28Y historyFree accessUpdated daily

Revenue growth remains highly unstable, swinging from a 193.2% surge in 2024Q1 to a 12.9% contraction by 2025Q4, while gross margins have fluctuated between 29.1% and 56.3% over the last ten quarters.

CRESW Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98
Sales/Revenue914.16B711.37B707.41B767.7B149.93B82.24B47.53B93.27B67.91B15.62B5.65B4.6B3.53B2.86B2.54B1.88B1.43B345.42M208.26M177.89M145.62M69.89M72.34M72.67M34.8M35.13M43.61M52.96M
Revenue Growth %28.51%0.56%-7.85%412.04%82.3%73.04%-49.04%37.34%334.69%176.4%22.76%30.48%23.38%12.58%34.95%31.89%313.17%65.86%17.07%22.16%108.36%-3.39%-0.45%108.85%-0.95%-19.44%-17.67%-
Cost of Goods Sold575.82B419.82B437.81B427.61B121.69B47.24B23.55B59.87B42.7B8.77B3.3B2.78B2.22B1.76B1.49B994.13M851.19M259.75M171.07M159.19M126.65M45.26M51.32M40.23M27.16M27.79M41.81M35.97M
COGS % of Revenue62.99%59.02%61.89%55.7%81.16%57.44%49.54%64.19%62.89%56.15%58.42%60.34%62.97%61.56%58.51%52.81%59.64%75.2%82.14%89.49%86.97%64.75%70.94%55.36%78.06%79.12%95.88%67.92%
Gross Profit338.33B291.55B269.6B340.1B28.24B35B23.98B33.39B25.2B6.85B2.35B1.83B1.31B1.1B1.05B888.22M575.98M85.67M37.19M18.7M18.97M24.63M21.02M32.44M7.63M7.33M1.8M16.99M
Gross Margin %37.01%40.98%38.11%44.3%18.84%42.56%50.46%35.81%37.11%43.85%41.58%39.66%37.03%38.44%41.49%47.19%40.36%24.8%17.86%10.51%13.03%35.25%29.06%44.64%21.94%20.88%4.12%32.08%
Gross Profit Growth %16.05%8.14%-20.73%1104.19%-19.3%45.94%-28.18%32.5%267.87%191.53%28.7%39.76%18.85%4.3%18.67%54.21%572.33%130.36%98.84%-1.4%-23%17.18%-35.2%324.98%4.07%308.53%-89.43%-
Operating Expenses187.49B427.79B345.35B-6.13B-6.84B-72.95B65.69B1.54B21.06B-12.75B-3.4B640M200.19M452.34M326.89M301.25M360.58M42.06M46.16K7.58M-17.27M6.76M-6.78M19.35M6.82M10.32M10.66M11.36M
OpEx % of Revenue20.51%60.14%48.82%-0.8%-4.56%-88.7%138.21%1.65%31.01%-81.6%-60.08%13.9%5.67%15.82%12.87%16%25.27%12.18%0.02%4.26%-11.86%9.67%-9.37%26.63%19.59%29.39%24.45%21.44%
Selling, General & Admin196.03B106.21B117.75B95.86B23B11.33B8.42B22.17B16.4B3.7B1B834M573.03M482.39M432.22M459.13M347.15M40.6M31.35M25.58M22.39M14.26M10.41M16.58M8.75M8.64M9.12M9.97M
SG&A % of Revenue21.44%14.93%16.65%12.49%15.34%13.77%17.71%23.77%24.14%23.67%17.78%18.11%16.24%16.87%17.01%24.39%24.32%11.75%15.05%14.38%15.38%20.4%14.39%22.82%25.13%24.58%20.92%18.82%
Research & Development0000000000000000000000000000
R&D % of Revenue----------------------------
Other Operating Expenses-8.54B321.58B227.6B-101.99B-29.84B-84.28B57.28B-20.63B4.66B-16.44B-4.4B-194M-372.83M-30.05M-105.34M-157.88M13.43M1.46M-31.31M-17.99M-39.67M-7.5M-17.19M2.77M-1.93M1.69M1.54M1.39M
Operating Income150.85B-136.24B-75.75B346.23B35.08B107.95B-41.71B31.86B4.15B19.6B5.75B1.19B1.11B646.96M727.13M586.97M215.4M43.61M37.14M11.12M36.24M17.87M27.8M13.09M818.51K-2.99M-8.87M5.63M
Operating Margin %16.5%-19.15%-10.71%45.1%23.4%131.26%-87.76%34.16%6.11%125.45%101.66%25.76%31.35%22.62%28.62%31.18%15.09%12.63%17.83%6.25%24.89%25.57%38.43%18.01%2.35%-8.51%-20.34%10.64%
Operating Income Growth %210.73%-79.85%-121.88%886.85%-67.5%358.81%-230.93%668.19%-78.84%241.07%384.49%7.2%71.01%-11.03%23.88%172.5%393.91%17.42%234.04%-69.32%102.78%-35.71%112.34%1499.36%127.37%66.28%-257.38%-
EBITDA167.09B-125.66B-65.76B356.12B38.03B112.78B-40.98B41.6B11.99B21.14B5.86B1.48B1.39B880.09M851.85M722.96M303M50.09M41.5M16.24M40.41M21.82M31.37M16.72M2.51M-1.3M-7.33M7.02M
EBITDA Margin %18.28%-17.66%-9.3%46.39%25.36%137.13%-86.21%44.6%17.65%135.34%103.64%32.21%39.28%30.77%33.53%38.41%21.23%14.5%19.93%9.13%27.75%31.22%43.37%23.01%7.2%-3.7%-16.8%13.26%
EBITDA Growth %232.96%-91.08%-118.47%836.44%-66.28%375.25%-198.5%247.05%-43.31%260.93%295.01%6.99%57.49%3.32%17.83%138.6%504.96%20.69%155.59%-59.82%85.17%-30.44%87.62%567.12%292.77%82.25%-204.32%-
D&A (Non-Cash Add-back)16.24B10.57B9.99B9.89B2.94B4.83B735M9.74B7.84B1.54B112M297M279.74M233.14M124.72M135.99M87.59M6.47M4.36M5.12M4.17M3.95M3.57M3.63M1.69M1.69M1.54M1.39M
EBIT351.88B93.01B103.73B13.12B89.91B99.2B-55.01B406M10.36B16.77B4.51B-1.08B661.25M490.26M797.87M698.01M215.4M23.5M37.14M11.12M36.24M17.87M27.8M13.09M818.51K-2.99M-8.87M5.63M
Net Interest Income-73.96B24.72B-75.29B-90.9B-40.51B-21.44B-9.4B-19.07B-13.18B-2.71B-914M-685M-470.72M-429.16M-271.85M-158.53M-1.1M4.83M0000000000
Interest Income9.41B85.62B8.17B21.75B8.06B2.08B289M321M552M-27M-40M30M72.81M22.6M19.01M23.28M13.66M4.83M0000000000
Interest Expense83.36B60.9B83.46B112.67B48.57B23.51B9.69B19.39B13.74B2.69B874M715M473.46M409.82M290.85M181.81M93K00000000000
Other Income/Expense144.56B168.34B96.03B174.19B6.26B-32.26B-22.98B-50.84B-7.53B-5.51B-2.11B-2.98B-918.58M-566.52M-220.11M-70.77M96.11M-20.11M19.55M27.34M78.21M22.8M48.24M-45.91M5.07M4.37M9.93M13.27M
Pretax Income295.41B32.11B20.28B520.42B41.34B75.69B-64.69B-18.98B-3.38B14.09B3.64B-1.8B187.78M80.44M507.02M516.2M311.51M23.5M56.69M38.46M114.45M40.67M76.03M-32.82M5.89M1.38M1.06M18.91M
Pretax Margin %32.32%4.51%2.87%67.79%27.58%92.03%-136.11%-20.36%-4.98%90.17%64.38%-39.05%5.32%2.81%19.96%27.42%21.83%6.8%27.22%21.62%78.59%58.19%105.11%-45.16%16.92%3.92%2.43%35.7%
Income Tax71.05B-61.87B-270.18B15.83B98.77B19.59B820M-9.96B1.83B5.79B1.4B-389M33.52M21.96M110.07M145.95M92.68M284K8.18M5.44M37.77M8.6M10.66M7.78M2.05M22.37K18K38.76K
Effective Tax Rate %24.05%-192.7%-1332.38%3.04%238.9%25.89%-1.27%52.48%-54.23%41.07%38.36%21.64%17.85%27.3%21.71%28.27%29.75%1.21%14.44%14.14%33%21.14%14.01%-23.7%34.87%1.62%1.7%0.21%
Net Income96.15B78.46B162.99B297.05B-44.43B9.68B-40.25B6.11B-624M5.17B954M-1.07B-26.91M-21.33M221.93M185.41M124.62M22.95M48.24M32.92M76.77M32.21M65.38M-40.6M3.83M1.35M1.04M18.87M
Net Margin %10.52%11.03%23.04%38.69%-29.64%11.77%-84.68%6.55%-0.92%33.08%16.88%-23.2%-0.76%-0.75%8.74%9.85%8.73%6.64%23.16%18.51%52.72%46.09%90.38%-55.87%11.02%3.86%2.39%35.63%
Net Income Growth %22.54%-51.86%-45.13%768.54%-559.11%124.05%-759.15%1078.53%-112.08%441.61%189.33%-3869.23%-26.15%-109.61%19.7%48.78%443.04%-52.43%46.53%-57.12%138.31%-50.73%261.03%-1158.83%183.1%30.14%-94.48%-
Net Income (Continuing)224.37B93.98B290.46B504.59B-57.43B56.1B-65.51B-9.02B-5.21B8.3B2.24B-1.41B154.26M58.48M396.95M370.25M218.83M23.21M48.24M32.92M76.77M32.21M65.38M-40.6M3.83M1.35M1.04M18.87M
Discontinued Operations0000-29.19B04.33B36.44B8.84B817M000000000000000000
Minority Interest1.24T867.67B1.02T268.37B120.44B145.68B103.16B86.21B32.77B23.54B6.53B5.73B2.21B2.13B2.48B1.63B1.44B1.16M817.8K560.49K276.83K65.67K207.83K393.63K243K59.42K02.02M
EPS (Diluted)145.22111.80237.94437.48-80.887.96-73.9611.45-1.189.321.56-1.93-0.040.120.340.300.190.050.130.110.210.080.16-0.280.030.010.010.13
EPS Growth %29.89%-53.01%-45.61%640.9%-1116.08%110.76%-745.94%1070.34%-112.66%497.44%180.83%-4198.44%-137.42%-64.71%13.33%57.89%275.49%-61.08%18.18%-47.62%156.41%-48.81%157.14%-1137.04%---94.15%-
EPS (Basic)160.78132.44270.75487.77-80.888.21-73.9611.91-1.189.451.76-1.93-0.040.140.380.340.220.050.160.160.410.190.45-0.280.030.010.010.13
Diluted Shares Outstanding662.09M702M691.75M685.69M544M531.25M531.21M532.99M527.67M554.75M612.22M552.37M552.99M629.53M629.53M618.25M645.42M456.99M380.98M300.03M380.98M393.28M405.85M142.03M141.92M141.94M147.41M147.41M
Basic Shares Outstanding598M592M685M679.01M549.36M515.02M515.45M512.64M527.67M547.02M543.7M552.37M552.99M559.3M559.3M548.02M575.16M437.02M293.13M205.28M184.25M162.65M145.14M142.03M141.92M141.94M147.41M147.41M
Dividend Payout Ratio90.93%157.52%99.98%22.42%-26.37%-15.39%-4.63%3.56%---31.09%32.36%34.56%35.95%11.14%30.41%3.91%4.67%2.64%-33.56%811.87%362.6%-

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

Hyperinflationary currency volatility

Volatile Revenue Growth Patterns Observed

According to the provided quarterly income statements, CRESW experienced significant revenue fluctuations, ranging from a 193.2% surge in 2024Q1 to a 12.9% contraction by 2025Q4, reflecting the inherent instability of its commodity-linked agricultural business and the lumpy nature of its real estate divestment strategy.

The erratic top-line performance suggests that revenue is heavily influenced by the timing of land sales and seasonal harvest cycles rather than consistent operational growth. Investors should monitor whether the recent contraction in 2025Q4 indicates a structural slowdown in asset recycling or merely a temporary pause in the company's opportunistic divestment cycle.

Structural Margin Compression and Instability

As reported in financial statements, gross margins have exhibited extreme variability, dropping from a peak of 56.3% in 2024Q2 to a low of 29.1% in 2025Q1, highlighting the company's sensitivity to domestic Argentine inflationary pressures and fluctuating commodity input costs across its diverse operational segments.

The wide margin swings appear to be exacerbated by the interplay between local-currency operating costs and USD-denominated revenue streams. This volatility warrants further investigation into how management navigates the hyperinflationary environment, as the current margin profile suggests limited pricing power in the face of rising domestic expenses.

Non-Operating Items Distort Earnings Quality

Based on the company's reported figures, net income has frequently decoupled from operating performance, with significant quarterly swings such as the $126.0B profit in 2024Q1 followed by a $18.8B loss in 2025Q2, indicating that non-operating items and fair value adjustments heavily influence the bottom line.

The reliance on fair value accounting for biological assets and real estate holdings makes reported net income a poor proxy for underlying cash generation. Analysts should be cautious, as these non-cash adjustments may mask the true operational health of the business during periods of extreme macroeconomic volatility.

Sovereign Risk and Structural Complexity

Data from recent filings suggests that CRESW's reliance on the Argentine macro environment creates a persistent risk profile, where the company's complex holding structure and exposure to currency controls may obscure the actual liquidity available to service its significant debt obligations at the holding company level.

Short-term observers might focus on the potential for further margin compression if domestic inflation continues to outpace currency devaluation. The persistent 'conglomerate discount' appears justified by the difficulty in isolating value within the IRSA-linked urban portfolio, which may remain a drag on performance during domestic economic downturns.

CRESW — Frequently Asked Questions

Quick answers to the most common questions about buying CRESW stock.

What was Cresud S.A. Warrant 2021-08.03.26 on Cresud's (CRESW) revenue in 2025?

For fiscal year 2025, Cresud S.A. Warrant 2021-08.03.26 on Cresud (CRESW) reported total revenue of $914.16B. This represents a 1725948.2% increase compared to $53.0M in 1998.

Is Cresud S.A. Warrant 2021-08.03.26 on Cresud (CRESW) profitable?

Cresud S.A. Warrant 2021-08.03.26 on Cresud (CRESW) is profitable, generating $96.15B in net income for the fiscal year ending 2025 with a net profit margin of 10.5%.

What is Cresud S.A. Warrant 2021-08.03.26 on Cresud's operating profit margin?

Cresud S.A. Warrant 2021-08.03.26 on Cresud (CRESW) reported an operating income of $150.85B, resulting in an operating profit margin of 16.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Cresud S.A. Warrant 2021-08.03.26 on Cresud's gross profit and gross margin?

Cresud S.A. Warrant 2021-08.03.26 on Cresud (CRESW) generated $338.33B in gross profit for the year, representing a gross profit margin of 37.0%. This demonstrates the company's core pricing power and production efficiency.